Answers are grounded in this paper and cite their sources.
A case vignette is presented of a patient with recurrent prostate cancer after radical prostatectomy, covering the spectrum from biochemical recurrence to metastatic disease. The patient provides his insight into this journey as he is treated on serial clinical trials as the disease recurs.
No takes yet. Share an insight, caveat, or question.
Kishan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: